New Zealand
Brandon Capital Raises $180M Fund to Boost Australia and New Zealand Biotechs
Brandon Capital, biotechs, Australia, New Zealand, life sciences, venture capital, fund, startups, scale-ups
Minimal Weight Reduction Observed with Low Doses of New Zealand’s GLP-1/GLP-2 Agonist
New Zealand, GLP-1/GLP-2 agonist, weight reduction, lowest doses, minimal effect.